California Will Vote on $8.4 Billion Immunology Bond
In November 2026, California residents will decide whether to approve state funding for large-scale immunology research.
Updated on Oct. 14, 2026 in Allergies
Live Poll
Should California issue $8.4 billion in bonds to fund biomedical and immunology research?
California voters will head to the polls on November 3, 2026, to decide on Proposition 38, a measure authorizing $8.4 billion in general obligation bonds for immunology research. This funding initiative aims to support medical advancements across the state.
Why it matters
The measure seeks to address potential gaps in medical science funding as federal budget discussions unfold. Voters are weighing whether to increase state investment to offset proposed national NIH funding cuts.
Proposition 38 authorizes $8.4 billion in state bond funding, with $4.2 billion specifically designated for the California Institute for Immunology and Immunotherapy. While the measure outlines broad support for disease research, specific long-term outcomes remain subject to voter approval.
The players
California Department of Public Health
The state agency responsible for evaluating research institutes against bond criteria.
Gary K. Michelson
A founder of the California Institute for Immunology and Immunotherapy.
Meyer Luskin
A founder of the California Institute for Immunology and Immunotherapy.
California Institute for Immunology and Immunotherapy
A research entity expected to qualify for half of the proposed state bond funds.
The details
The bond proceeds are managed by the California Department of Public Health, which determines institutional eligibility based on specific bond criteria. Half of the total funding is earmarked for cancer, heart disease, and Alzheimer's research, while the remainder supports broader immunological studies. The California Institute for Immunology and Immunotherapy, founded by Gary K. Michelson and Meyer Luskin, is expected to qualify for $4.2 billion of the total allocation.
Timeline
November 3, 2026: California voters will decide on Proposition 38.
2027: Planned implementation of proposed federal NIH funding cuts.
Health Landscape
This bond measure arrives as states increasingly look to secure domestic research funding to mitigate reliance on federal grants. Proposition 38 functions as a state-level supplement to the National Institutes of Health (NIH) federal research budget.
This measure may influence the availability of local clinical trials and specialized research programs in California. You may want to monitor how this funding affects the availability of treatments for conditions like cancer and Alzheimer's in your area.
The takeaway
Proposition 38 reflects a major shift in how states may fund local medical research in response to federal budget changes. Residents should review official voter guides to understand how the allocation of these bonds could impact local research priorities.
What happens next
California voters will cast their ballots for Proposition 38 on November 3, 2026.
Further reading
For more on the research priorities shaping state medical initiatives, visit Allergies.
Source note: This article includes information reported by ABC7.
Live Poll
Should California issue $8.4 billion in bonds to fund biomedical and immunology research?
